Statistics
Publications
1
Citations
22
H-Index
1
Active since
2024
Affiliations
EA Pharma (Japan)(Current)
Rong Feng Fu is an author at EA Pharma (Japan) specializing in jak2 v617f mutation, interferon-based therapy, and hematologic oncology.
Publications per year
2024–2024
1
1
Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment
S. Suo, Rong Feng Fu, Albert Qin et al. · Journal of Hematology · 2024 · 22 citations · Full text
Medicine, Hematology, Pharmacology +10
1–1 of 1